Remedy for hypertension

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

10504585

ABSTRACT:
A therapeutic agent for hypertension, which comprises as an active ingredient a compound capable of inhibiting Na+/Ca2+exchanger 1.

REFERENCES:
patent: 6156801 (2000-12-01), Ota et al.
patent: 6162832 (2000-12-01), Ota et al.
patent: 6423705 (2002-07-01), Tracey et al.
patent: 2002/0082193 (2002-06-01), Anderson et al.
patent: 2002-233376 (2002-08-01), None
patent: WO98/43943 (1998-10-01), None
patent: WO99/20598 (1999-04-01), None
Medline Accession No. 95067100, an abstract of Kashiwagi et al., Acta neurochirurgica, Supplementum, (1994), vol. 60, pp. 289-292.
Biosis Accession No. 2001:285417, an abstract of Yamashita et al., Journal of Pharmacology and Experimental Therapeutics, (Feb., 2001), vol. 286, No. 2, pp. 412-419.
Cecil Textbook of Medicine, 21st Edition, vol. 1, published 2000 by W.B.Saunders Company (PA), pp. 258-273.
Yamashita, Junji, et al., “Pre- or Post—Ischemic Treatment with a Novel Na+/Ca2+Exchange Inhibitor, KB-R7943, Shows Renal Protective Effects in Rats with Ischemic Acute Renal Failure”,The Journal of Pharmacology and Experimental Therapeutics, Feb., 2001, vol. 296, No. 2, pp. 412-419.
Kashiwagi, F. et al., “Effects of a new calcium antagonist (SM-6586) on experimental cerebral ischemia.”,Acta. Neurochirurgica. Supplementum, 1994, vol. 60, pp. 289-292 (abstract) Medline [online]: Retrieved from STN, Medline Accession No. 95067100.
Yamashita, Junji, et al., “Pre- or Post—Ischemic Treatment with a Novel Na+/Ca2+Exchange Inhibitor, KB-R7943, Shows Renal Protective Effects in Rats with Ischemic Acute Failure”,The Journal of Pharmacology and Experimental Therapeutics, Feb., 2001, vol. 296, No. 2, pp. 412-419.
Kashiwagi, F. et al., “Effects of a new calcium antagonist (SM-6586) on experimental cerebral ischemia.”,Acta. Neurochirurgica. Supplementum, 1994, vol. 60, pp. 289-292 (Full Article Considered).
Kashiwagi, F. et al., “Effects of a new calcium antagonist (SM-6586) on experimental cerebral ischemia.”,Acta. Neurochirurgica. Supplementum, 1994, vol. 60, pp. 289-292 (abstract) Medline [online]: Retrieved from STN, Medline Accession No. 95067100.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Remedy for hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Remedy for hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Remedy for hypertension will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3891360

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.